Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lawmakers Press OMB To Release Lab-Developed Test Draft Guidance

This article was originally published in The Gray Sheet

Executive Summary

In a letter to Office of Management and Budget director Sylvia Mathews, nine Democratic representatives urged the release of a draft guidance establishing an FDA oversight structure for laboratory-developed tests. FDA said more than a year ago that the documents were under administrative review.

Advertisement

Related Content

Senators Push OMB For Lab-Developed Test Guidance, Academic Labs Resist
Senators Push OMB For Lab-Developed Test Guidance, Academic Labs Resist
FDA Approves First Next-Generation DNA Sequencing Platforms
FDA Approves First Next-Generation DNA Sequencing Platforms
Lab-Developed Test Regs In Spotlight With Citizen Petition, Hamburg Speech
FDA Aims To Finalize Framework For Lab-Developed Tests In Near Term
Would Expanded Lab-Test Regulation Overstep FDA’s Legal Limits?

Topics

Advertisement
UsernamePublicRestriction

Register

MT032330

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel